Goldman Sachs Reports 5.2% Passive Stake in Indivior PLC (INVVY)
INDIVIOR PLC
Subscribe to track INVVY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Goldman Sachs Reports 5.2% Passive Stake in Indivior PLC (INVVY)
Company: INDIVIOR PLC (INVVY) Form: SCHEDULE 13G/A | Filed: 2025-11-12 Significance: Medium
Reporting Entity: THE GOLDMAN SACHS GROUP, INC. Relationship: Institutional Investor / >5% Owner
Holding Details: • Type: Statement of Passive Ownership • Security: Ordinary Shares • Shares Held: 6,531,869 • Stake: 5.2% of class
Key Insight: This filing amends Goldman Sachs' previously disclosed passive investment in the pharmaceutical company Indivior PLC, reaffirming their position as a significant institutional shareholder with a 5.2% stake.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: INDIVIOR PLC
Executive Summary
- Trading Significance: Medium
- Key Takeaway: Goldman Sachs Group filed a Schedule 13G/A, amending its reported passive ownership stake in Indivior PLC to 6,531,869 shares, representing 5.2% of the company's ordinary shares.
- Market Impact: This filing reaffirms a significant, passive institutional position, which is generally a neutral to slightly positive signal of stability for the subject company, Indivior PLC.
Filing Information
| Field | Value |
|---|---|
| Subject Company | INDIVIOR PLC |
| Subject CIK | 0001625297 |
| Ticker Symbol | INVVY (ADR) |
| Filer | THE GOLDMAN SACHS GROUP, INC. |
| Filer CIK | 0000886982 |
| Form Type | SCHEDULE 13G/A |
| Event Date | 2025-09-30 |
Ownership Details
| Field | Value |
|---|---|
| Security Type | Ordinary shares, $0.50 nominal value per share |
| Shares Beneficially Owned | 6,531,868.75 |
| Percent of Class | 5.2% |
| Shared Voting Power | 6,531,833.75 |
| Shared Dispositive Power | 6,531,868.75 |
| Nature of Ownership | Passive Investment (Not for control) |
Financial Impact Assessment
Transaction Materiality
Note: The provided market data pertains to the filer (Goldman Sachs), not the subject company (Indivior PLC). Therefore, a quantitative analysis of the holding's value as a percentage of Indivior PLC's market capitalization cannot be performed.
Impact Evaluation
- Ownership Concentration: Goldman Sachs holds a 5.2% stake, making it a significant institutional owner. Such a position can provide a degree of share price stability. As a passive stake (Rule 13d-1(b)), it indicates the investment is not intended to influence the control of Indivior PLC.
- Institutional Conviction: This amended filing reaffirms Goldman Sachs' position in the specialty pharmaceutical company. While it's an amendment and not a new position, maintaining a stake above the 5% reporting threshold is a notable data point for investors tracking institutional money flow.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is an amendment to an existing passive holding, not a new purchase or activist campaign. It confirms the status quo of Goldman Sachs being a major shareholder, which is already known to the market. The filing itself is unlikely to cause significant price movement.
Volume & Sentiment
- Expected Volume Impact: Low. Schedule 13G/A filings, especially from large institutions, are routine disclosures and rarely drive short-term trading volume.
- Sentiment Indicator: Neutral. The filing confirms a large institution's continued passive investment, which can be viewed as a sign of stability, but it does not signal any new bullish or bearish catalyst.
Investment Insights
Key Takeaways
- Significant Institutional Stake: Goldman Sachs remains a major shareholder in Indivior PLC with a 5.2% passive stake.
- Passive Investment: The filing under Rule 13d-1(b) certifies that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
- Amendment Filing: This is an update (Amendment No. 2) to a previously reported position, not the initiation of a new stake, making it a routine disclosure.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.
